Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

6.6K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in predicting T cell epitope recognition for cancer immunotherapy.

Nature cancer·2026
Same author

Predicting TCR-epitope recognition: How good are we?

Cell genomics·2025
Same author

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Science advances·2025
Same author

Phage display enables machine learning discovery of cancer antigen-specific TCRs.

Science advances·2025
Same author

Predicting MHC-I ligands across alleles and species: how far can we go?

Genome medicine·2025
Same author

Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Science advances·2025

Related Experiment Video

Updated: Aug 14, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

12.6K

Contemplating immunopeptidomes to better predict them.

David Gfeller1, Yan Liu1, Julien Racle1

  • 1Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland; Agora Cancer Research Centre, 1011 Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), 1011 Lausanne, Switzerland.

Seminars in Immunology
|January 9, 2023
PubMed
Summary
This summary is machine-generated.

Identifying T-cell epitopes is crucial for understanding immunity in diseases and cancer. Advances in mass spectrometry and computational analysis improve the prediction of these key immune targets, aiding vaccine and therapy development.

Keywords:
Antigen presentationEpitope predictionsImmunopeptidomicsMachine learning

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Related Experiment Videos

Last Updated: Aug 14, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

12.6K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Area of Science:

  • Immunology
  • Computational Biology
  • Proteomics

Background:

  • T-cell epitopes are vital for immune recognition in infectious diseases, autoimmunity, and cancer.
  • They serve as targets for personalized vaccines and T-cell therapies, particularly in cancer immunotherapy.
  • T-cell epitopes are short peptides presented by Major Histocompatibility Complex (MHC) molecules.

Purpose of the Study:

  • To review computational developments for analyzing experimentally determined immunopeptidomes.
  • To enhance understanding of antigen presentation and MHC binding specificities.
  • To improve the prediction of MHC ligands and T-cell epitopes.

Main Methods:

  • Analysis of mass spectrometry (MS)-based immunopeptidome profiling data.
  • Review of computational algorithms for MHC ligand prediction.
  • Discussion of methods for predicting T-cell receptor (TCR) recognition and immunogenicity.

Main Results:

  • Mass spectrometry techniques have identified vast numbers of MHC-presented peptides, including T-cell recognized epitopes.
  • Experimental data have revealed fundamental properties of antigen presentation pathways.
  • Computational approaches have significantly improved the prediction of naturally presented MHC ligands and T-cell epitopes.

Conclusions:

  • Computational analysis of immunopeptidomes is essential for advancing our understanding of antigen presentation.
  • Improved prediction of MHC ligands and T-cell epitopes has implications for therapeutic strategies.
  • Future research should focus on predicting TCR recognition and immunogenicity beyond antigen presentation.